Ask AI
ProCE Banner Series

Precision in Progress: Advancing Personalized Care in EGFR Mutation–Positive NSCLC Care

This live and enduring program is designed to improve awareness, knowledge, confidence, and competence on recent data presented by experts to facilitate up-to-date clinical management of patients with EGFRm NSCLC. The experts will cover how new therapies are poised to transform NSCLC care, including how to approach treatment for tumors with EGFR exon 20 insertion mutations. 

  AMA
Who Should Attend

This activity is intended for medical oncologists, pulmonologists, and other healthcare professionals caring for patients with NSCLC.

All Events

Precision in Progress: Advancing Personalized Care in EGFR Mutation–Positive NSCLC Care

Upcoming Events

March

06

2026

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Non-small cell lung cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, competence, and confidence in evaluating and applying emerging clinical data to patient-centered treatment plans for patients with EGFR-mutated NSCLC, ultimately improving patient outcomes. 

Target Audience
This activity is intended for medical oncologists, pulmonologists, and other healthcare professionals caring for patients with NSCLC.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Apply clinical trial evidence to guide the personalized use of EGFR-targeted monotherapies, combinations, and antibody–drug conjugates across the EGFRm NSCLC disease continuum, including post-progression and earlier stages of disease
  • Assess and mitigate adverse events associated with novel EGFR-directed therapies using evidence-based management strategies to optimize adherence and quality of life
  • Integrate patient-specific factors—including molecular resistance patterns, prior treatment exposure, comorbidities, and preferences—into individualized treatment planning for EGFRm NSCLC
  • Evaluate the latest evidence on emerging agents and combinations for patients with EGFR Exon 20 mutation-positive NSCLC

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Clinical Care Options, LLC dba Decera Clinical Education's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC dba Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Taiho Oncology, Inc.

Taiho Oncology Inc

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191